Ghent University Academic Bibliography

Journal Article
A1
open access

Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial

Thomas Zilli, Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2026) EUROPEAN UROLOGY ONCOLOGY.

Add to list

Journal Article
A1
open access

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy

Elke Rammant (UGent) , Emile Deman (UGent) , Valerie Fonteyne (UGent) , Lindsay Poppe (UGent) , Renée Bultijnck (UGent) , Piet Dirix, Gert De Meerleer, Karin Haustermans, Ann Van Hecke (UGent) , Miguel E. Aguado-Barrera, et al.

(2026) HEALTH AND QUALITY OF LIFE OUTCOMES. 24(1).

Add to list

Journal Article
A1
open access

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Flor Verghote (UGent) , Elke Rammant (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Sara Junius, Nick Liefhooghe, Leen Noé, Piet Ost (UGent) , Karel Decaestecker (UGent) , et al.

(2025) EUROPEAN UROLOGY FOCUS. 11(4). p.595-602

Add to list

Journal Article
A1
open access

Stage migration on prostate-specific membrane antigen positron emission tomography/computed tomography in comparison to conventional imaging in patients with high-risk prostate cancer referred for radiation therapy : results from the phase 2/3 THUNDER trial

Fleur Kleiburg, Piet Dirix, Valerie Fonteyne (UGent) , Samuel Bral, Bart De Troyer, Brieuc Sautois, Mareva Lamande, Nick Liefhooghe, Guillaume Grisay, Sabine Meersschou, et al.

(2025) EUROPEAN UROLOGY ONCOLOGY. 8(5). p.1333-1339

Add to list

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, Francois-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2025) LANCET ONCOLOGY. 26(6). p.695-706

Add to list

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Flor Verghote (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Ben Vanneste (UGent) , Sara Junius, Nick Liefhooghe, Leen Noé, Gert De Meerleer, Piet Ost (UGent) , et al.

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 194(Supplement 1). p.S2308-S2311

Add to list

Journal Article
A1
open access

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Sebastian M. Christ, Filippo Alongi, Umberto Ricardi, Marta Scorsetti, Lorenzo Livi, Panagiotis Balermpas, Yolande Lievens (UGent) , Pètra Braam, Barbara Alicja Jereczek-Fossa, Karin Stellamans, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 195.

Add to list

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY. 7(3). p.462-468

Add to list

Journal Article
A1
open access

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Flor Verghote (UGent) , Paul Sargos, John P. Christodouleas, Vedang Murthy, Brian C. Baumann, Piet Dirix, Charlien Berghen, Leen Paelinck (UGent) , Tom Vercauteren (UGent) and Valerie Fonteyne (UGent)

(2022) PRACTICAL RADIATION ONCOLOGY. 12(6). p.524-532

Add to list

Can medical imaging identify the histopathological growth patterns of liver metastases?

Emily Latacz, Pieter-Jan van Dam, Christian Vanhove (UGent) , Laura Llado, Benedicte Descamps (UGent) , Núria Ruiz, Ines Joye, Dirk Grünhagen, Steven Van Laere, Piet Dirix, et al.

(2021) SEMINARS IN CANCER BIOLOGY. 71. p.33-41

Academic Bibliography

Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Stage migration on prostate-specific membrane antigen positron emission tomography/computed tomography in comparison to conventional imaging in patients with high-risk prostate cancer referred for radiation therapy : results from the phase 2/3 THUNDER trial

Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Can medical imaging identify the histopathological growth patterns of liver metastases?

Contents

Support

Contact